Pfizer Consumer Healthcare Revenue Is “On Plan,” McKinnell Says
This article was originally published in The Tan Sheet
Executive Summary
Pfizer's Consumer Healthcare unit is doing "just fine" despite a 5% decrease in first-quarter sales, CEO Hank McKinnell said during an April 19 earnings call
You may also be interested in...
J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare extends the firm's reach in the global OTC market and provides entry into several new product categories
J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare extends the firm's reach in the global OTC market and provides entry into several new product categories
J&J Picks Up Listerine, Nicorette With $16.6 Bil. Purchase Of Pfizer OTCs
Johnson & Johnson's successful bid to acquire Pfizer Consumer Healthcare extends the firm's reach in the global OTC market and provides entry into several new product categories